Related Experiment Video
Updated: Jul 16, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
A framework for drug utilization evaluation in depression: insights from outcomes research
E T Edgell1, K H Summers, T R Hylan
1Global Health Economics Research, Eli Lilly and Company, Indianapolis, IN 46285, USA.
Medical Care
|April 27, 1999
Summary
Drug utilization evaluation (DUE) can enhance depression care by addressing drug-related problems (DRPs). Outcomes research provides a foundation for developing DUE criteria and interventions in outpatient settings.
Area of Science:
- Pharmacoeconomics
- Clinical Pharmacy
- Mental Health Services Research
Background:
- Drug utilization evaluation (DUE) aims to improve depression care quality by identifying and resolving drug-related problems (DRPs).
- Outcomes research in depression offers valuable data for implementing DUE programs in managed care outpatient settings.
Purpose of the Study:
- To guide the development of a drug utilization evaluation (DUE) program for outpatient depression care.
- To establish a framework for addressing drug-related problems (DRPs) in depressed patients.
Main Methods:
- Comprehensive literature review on depression treatment, drug-related problems (DRPs), and outcomes research.
- Synthesis of reviewed information to create a framework for potential DUE criteria.
Main Results:
- Focusing DUE efforts on solving drug-related problems (DRPs) can significantly improve the quality of depression care.
- Outcomes research findings are crucial for establishing DUE criteria and guiding intervention selection.
Conclusions:
- Effective drug utilization evaluation (DUE) programs are essential for optimizing depression treatment.
- Utilizing outcomes research data is a key first step in developing targeted interventions for drug-related problems (DRPs).
More Related Videos
Related Concept Videos
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...